Covered recipient · General Payments record
LINDSAY LEGNON
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2021
$354.29
- Reported across 29 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $234.33 | 20 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $220.36 | 19 |
| ITI, Inc. | $13.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (20)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $8.02 | 01/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284025 | CMS |
| AbbVie Inc. | $6.48 | 01/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284031 | CMS |
| AbbVie Inc. | $4.82 | 02/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284037 | CMS |
| AbbVie Inc. | $7.74 | 02/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284043 | CMS |
| AbbVie Inc. | $9.66 | 03/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284049 | CMS |
| AbbVie Inc. | $17.28 | 04/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284053 | CMS |
| AbbVie Inc. | $4.99 | 04/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284059 | CMS |
| AbbVie Inc. | $16.35 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284065 | CMS |
| AbbVie Inc. | $3.86 | 05/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284071 | CMS |
| AbbVie Inc. | $17.10 | 05/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284077 | CMS |
| AbbVie Inc. | $10.76 | 06/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284083 | CMS |
| AbbVie Inc. | $4.71 | 06/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284089 | CMS |
| AbbVie Inc. | $17.76 | 08/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284093 | CMS |
| AbbVie Inc. | $17.43 | 09/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284099 | CMS |
| AbbVie Inc. | $22.71 | 09/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284105 | CMS |
| AbbVie Inc. | $9.02 | 09/29/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284111 | CMS |
| AbbVie Inc. | $12.16 | 10/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284117 | CMS |
| AbbVie Inc. | $14.42 | 11/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284123 | CMS |
| AbbVie Inc. | $15.09 | 12/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 795284129 | CMS |
| ITI, Inc. | $13.97 | 09/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 830152547 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.